Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T47101 | Target Info | |||
Target Name | Fibroblast growth factor receptor 1 (FGFR1) | ||||
Synonyms | c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR | ||||
Target Type | Successful Target | ||||
Gene Name | FGFR1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | AZD4547 | Ligand Info | |||
Canonical SMILES | CC1CN(CC(N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC | ||||
InChI | 1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+ | ||||
InChIKey | VRQMAABPASPXMW-HDICACEKSA-N | ||||
PubChem Compound ID | 51039095 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4RWJ Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) | ||||||
Method | X-ray diffraction | Resolution | 2.49 Å | Mutation | Yes | [1] |
PDB Sequence |
MAGVSEYELP
466 EDPRWELPRD476 RLVLGKPLGE486 GAFGQVVLAE496 AIGLDKDKPN506 RVTKVAVKML 516 KSDATEKDLS526 DLISEMEMMK536 MIGKHKNIIN546 LLGACTQDGP556 LYVIVEYASK 566 GNLREYLQAR576 RPPGLEYSYN586 PSHNPEEQLS596 SKDLVSCAYQ606 VARGMEYLAS 616 KKCIHRDLAA626 RNVLVTEDNV636 MKIADFGLAR646 DIHHIDYYKK656 TNGRLPVKWM 667 APEALFDRIY677 THQSDVWSFG687 VLLWEIFTLG697 GSPYPGVPVE707 ELFKLLKEGH 717 RMDKPSNCTN727 ELYMMMRDCW737 HAVPSQRPTF747 KQLVEDLDRI757 VALTSNQ |
|||||
|
LEU484
3.604
GLY485
3.211
PHE489
3.883
VAL492
4.232
ALA512
3.425
LYS514
3.228
LEU528
4.740
GLU531
3.429
MET535
3.831
ILE545
3.746
VAL559
3.729
VAL561
3.671
GLU562
2.972
|
|||||
PDB ID: 4RWK Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547) | ||||||
Method | X-ray diffraction | Resolution | 2.98 Å | Mutation | Yes | [1] |
PDB Sequence |
MAGVSEYELP
466 EDPRWELPRD476 RLVLGKPLGE486 GAFGQVVLAE496 AIGLDKDKPN506 RVTKVAVKML 516 KSDATEKDLS526 DLISEMEMMK536 MIGKHKNIIN546 LLGACTQDGP556 LYVIMEYASK 566 GNLREYLQAR576 RPPGLEYSYN586 PSHNPEEQLS596 SKDLVSCAYQ606 VARGMEYLAS 616 KKCIHRDLAA626 RNVLVTEDNV636 MKIADFGLAR646 DIHHIDYYKK656 TTNGRLPVKW 666 MAPEALFDRI676 YTHQSDVWSF686 GVLLWEIFTL696 GGSPYPGVPV706 EELFKLLKEG 716 HRMDKPSNCT726 NELYMMMRDC736 WHAVPSQRPT746 FKQLVEDLDR756 IVALTSNQ |
|||||
|
LEU484
3.307
GLY485
4.528
GLU486
4.890
GLY490
3.364
VAL492
3.044
ALA512
3.482
LYS514
3.313
ILE545
3.830
MET561
4.038
GLU562
2.928
TYR563
3.796
|
|||||
PDB ID: 4WUN Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) at 1.65 angstrom | ||||||
Method | X-ray diffraction | Resolution | 1.65 Å | Mutation | No | [2] |
PDB Sequence |
LPEDPRWELP
474 RDRLVLGKPL484 GEGAFGQVVL494 AEAIGLDKDK504 PNRVTKVAVK514 MLKSDATEKD 524 LSDLISEMEM534 MKMIGKHKNI544 INLLGACTQD554 GPLYVIVEYA564 SKGNLREYLQ 574 ARRPPLEYSY585 NPSHNPEEQL595 SSKDLVSCAY605 QVARGMEYLA615 SKKCIHRDLA 625 ARNVLVTEDN635 VMKIADFGLP663 VKWMAPEALF673 DRIYTHQSDV683 WSFGVLLWEI 693 FTLGGSPYPG703 VPVEELFKLL713 KEGHRMDKPS723 NCTNELYMMM733 RDCWHAVPSQ 743 RPTFKQLVED753 LDRIVALTSN763 QE
|
|||||
|
LEU484
3.655
GLY485
3.646
PHE489
3.809
VAL492
4.174
ALA512
3.456
LYS514
3.389
LEU528
4.698
GLU531
3.453
MET535
3.239
ILE545
3.799
VAL559
3.698
VAL561
3.565
GLU562
2.799
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Illuminating the molecular mechanisms of tyrosine kinase inhibitor resistance for the FGFR1 gatekeeper mutation: the Achilles' heel of targeted therapy.ACS Chem Biol.2015 May 15;10(5):1319-29. | ||||
REF 2 | The 1.65?? resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition. Acta Crystallogr D Biol Crystallogr. 2015 Mar;71(Pt 3):525-33. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.